TNPO1: A Promising Drug Target and Biomarker (G3842)

Target Name: TNPO1

NCBI ID: G3842

TNPO1

TNPO1: A Promising Drug Target and Biomarker

TNPO1 (TNPO1_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, lungs, and kidneys. It is a key regulator of the sodium levels in these tissues and is involved in the function of a number of physiological processes that are essential for human survival.

Research has identified TNPO1 as a potential drug target or biomarker for a number of conditions, including hypertension, heart failure, and kidney disease. The protein is also a good candidate for a diagnostic biomarker for these conditions, as its levels are often abnormal in individuals with these diseases.

One of the key reasons why TNPO1 is a promising drug target is its involvement in the regulation of sodium levels. High levels of sodium in the body can contribute to a number of health problems, including high blood pressure, which is a major risk factor for a range of cardiovascular diseases. TNPO1 plays a key role in regulating the levels of sodium in the body by controlling the movement of sodium into and out of cells.

In addition to its role in sodium regulation, TNPO1 is also involved in the function of many other physiological processes that are important for human survival. For example, it is involved in the regulation of water and electrolyte balance, as well as in the regulation of blood pressure and heart rate.

The identification of TNPO1 as a potential drug target has implications for the treatment of a wide range of conditions. For example, hypertension is a common condition that can be treated with a variety of medications, including diuretics, beta blockers, and ACE inhibitors. However, these treatments often have a negative impact on sodium levels and can contribute to the development of certain diseases. By targeting TNPO1, researchers may be able to develop new treatments for hypertension and other conditions that specifically target this protein.

In addition to its potential as a drug target, TNPO1 is also a promising biomarker for a number of diseases. Its levels are often abnormal in individuals with conditions such as heart failure, kidney disease, and liver disease. By using TNPO1 as a diagnostic biomarker, researchers may be able to develop new treatments for these conditions that specifically target this protein.

Overall, TNPO1 is a protein that has the potential to be a drug target or biomarker for a wide range of diseases. Its involvement in the regulation of sodium levels and its involvement in many other important physiological processes make it an attractive target for research and treatment. Further research is needed to fully understand the role of TNPO1 in human health and to develop new treatments based on this protein.

Protein Name: Transportin 1

Functions: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates (PubMed:24753571). May mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Involved in nuclear import of M9-containing proteins. In vitro, binds directly to the M9 region of the heterogeneous nuclear ribonucleoproteins (hnRNP), A1 and A2 and mediates their nuclear import. Involved in hnRNP A1/A2 nuclear export. Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5 (PubMed:11682607). In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones (By similarity). In vitro, mediates nuclear import of SRP19 (PubMed:11682607). Mediates nuclear import of ADAR/ADAR1 isoform 1 and isoform 5 in a RanGTP-dependent manner (PubMed:19124606, PubMed:24753571)

The "TNPO1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TNPO1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets